ClearEdge DANA, an FDA-cleared Class II clinical neurocognitive tool developed by Anthrotronix Inc., measures and monitors subtle changes in cognitive function. ClearEdge DANA is efficient and effective for a wide range of preventive and acute healthcare uses.

These include:

Preventive Care

  • Assess medical and psychological states.
  • Track changes in cognitive performance over time.
  • Screens for changes in neurobehavioral and cognitive function.
  • Deciphers change in cognitive reaction time and cognitive processing over time.

Geriatric Care

  • Monitor changes in cognitive efficiency over time to inform necessary lifestyle modifications.
  • Promote quality of life in conjunction with wellness exams.

Rehabilitative Care

  • Assess and track changes in cognition and reaction due to causes such as head injury, post-traumatic stress, etc.
  • Monitor changes and measure progress or decline after a stroke, illness, injury or other neurological incidents.
  • Track detailed changes in cognitive performance throughout treatment and recovery.


Comprehensive test reports detail the results of the cognitive assessments, providing baselines and data for comparison over multiple testing sessions.